Prognostic and Predictive Markers of Treatment Response in Patients With PAC.

RecruitingOBSERVATIONAL
Enrollment

4,050

Participants

Timeline

Start Date

January 1, 2003

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2031

Conditions
Pancreatic Adenocarcinoma
Trial Locations (15)

Unknown

RECRUITING

CHU Jean Minjoz, Besançon

RECRUITING

Hôpital Beaujon, Clichy

NOT_YET_RECRUITING

CHU - Henri Mondor, Créteil

RECRUITING

CHU Lille, Lille

NOT_YET_RECRUITING

Centre Léon Bérard, Lyon

RECRUITING

HRU Nancy Site Brabois, Nancy

RECRUITING

Hôpital Georges Pompidou, Paris

RECRUITING

Hôpital Saint Antoine, Paris

NOT_YET_RECRUITING

Institut Mutualiste Montsouris, Paris

NOT_YET_RECRUITING

CHU Poitiers, Poitiers

NOT_YET_RECRUITING

CHU Reims, Reims

NOT_YET_RECRUITING

CHU Pontchaillou, Rennes

NOT_YET_RECRUITING

Institut Curie, Saint-Cloud

NOT_YET_RECRUITING

IHU - Institut de chirurgie guidée par l'imagerie, Strasbourg

RECRUITING

Hôpital Paul Brousse, Villejuif

All Listed Sponsors
lead

GERCOR - Multidisciplinary Oncology Cooperative Group

OTHER

NCT05776342 - Prognostic and Predictive Markers of Treatment Response in Patients With PAC. | Biotech Hunter | Biotech Hunter